Purpose Fusions that involve neurotrophic-tropomyosin receptor kinase (fusions have been remarkably effective. samples), pediatric glioma (3.97%), and adult thyroid cancers (2.34%). Additional genomic and transcriptomic alterations mutation, amplification, and mRNA overexpressionoccurred in 14.2% of samples, whereas the frequency of alterations that implicated ligands and the co-receptor (p75NTR) ranged from 3.8% to 5.4%. Among 31 adult… Continue reading Purpose Fusions that involve neurotrophic-tropomyosin receptor kinase (fusions have been remarkably